Table 2.
LDL cholesterol in evolocumab treated patients stratified by baseline hsCRP.
| hsCRP |
P value | |||
|---|---|---|---|---|
| <1 mg/L [n = 132] | 1 – 3 mg/L [n = 170] | >3 mg/L [n = 111] | ||
| Baseline, mg/dL ± SD | 90.1 ± 24.7 | 92.7 ± 28.6 | 92.7 ± 27.9 | 0.65 |
| Weighted average, mg/dL ± SD | 32.1 ± 19.9 | 37.3 ± 25.1 | 35.9 ± 19.7 | 0.12 |
| Absolute Change, % ± SD | −58.0 ± 22.8 | −55.4 ± 30.7 | −56.8 ± 21.3 | 0.69 |